ACTU Competitors & Alternatives
Compare Actuate Therapeutics, Inc. Common stock with similar stocks in the same industry
Biotechnology
ACTU
Main Stock$0.71
Tradestie Score
52
Market Cap
$161.08M
Analyst Upside
+1537.0%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ACHV
Achieve Life Sciences, Inc.
|
$7.66
|
$158.43M | - | 42 | Compare |
|
NVCT
Nuvectis Pharma, Inc. Common Stock
|
$20.64
|
$154.27M | - | 59 | Compare |
|
CLYM
Climb Bio, Inc. Common Stock
|
$11.63
|
$133.50M | - | 53 | Compare |
|
STTK
Shattuck Labs, Inc. Common Stock
|
$6.62
|
$114.01M | - | 54 | Compare |
|
ANRO
Alto Neuroscience Inc.
|
$27.31
|
$110.20M | - | 63 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.63
|
$67.94M | - | 56 | Compare |
|
ACCL
ACCL
|
$2.64
|
$34.87M | 62.5 | 49 | Compare |
|
INDP
Indaptus Therapeutics, Inc. Common Stock
|
$2.84
|
$3.87M | - | 38 | Compare |
|
ACTL
ACTL
|
- | - | - | - | Compare |
|
CPWR
CPWR
|
- | - | - | - | Compare |
More ACTU Analysis
Data updated: Sep 29, 2026 | Industry: Biotechnology (SIC 2834)
231 stocks in this industry